Background: Transcranial Doppler (TCD) ultrasound can demonstrate dynamic information. We aimed to evaluate whether TCD generates useful additional information in the emergency room after a multimodal stroke imaging protocol and also whether this modified the management of patients with cerebral infarction. Methods: Patients admitted between April 2006 and June 2007 with ischemic stroke of less than 24 h were subjected to a protocol consisting of noncontrast brain CT, computed tomography angiography, diffusion-weighted magnetic resonance imaging and then TCD within the following 6 h by an observer blinded to the results of imaging studies. Results: Seventy-nine patients were included. The imaging protocol was performed 457 (±346) min after stroke symptoms and TCD after 572 (±376) min. TCD provided additional information in 28 cases (35.4%, 95% CI 25.7–46.4). More that one piece of additional information was obtained in 6 patients. The most frequent additional information was collateral pathways. Multivariate analysis demonstrated that intracranial vessel occlusion was the variable most associated with additional information. In 7 patients (8.8%, 95% CI 4.3–17.1), additional information changed management: in 4 an additional angiography was performed, in 2 patients angiography was suspended and in 1 aggressive neurocritical care was indicated. Patients with NIHSS >10 were significantly more likely to have their initial treatment changed (p = 0.004). Conclusions: TCD can provide additional information to a multimodal acute ischemic stroke imaging protocol in a third of patients. This can result in changes in the management in some of these patients.

1.
Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, Alexandrov AV: Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 2000;10:1–12.
2.
Navarro JC, Lao AY, Sharma VK, Tsivgoulis G, Alexandrov AV: The accuracy of transcranial Doppler in the diagnosis of middle cerebral artery stenosis. Cerebrovasc Dis 2007;23:325–330.
3.
Saqqur M, Hill MD, Alexandrov AV, Roy J, Schebel M, Krol A, Garami Z, Shuaib A, Demchuk AM: Derivation of power M-mode transcranial Doppler criteria for angiographic proven MCA occlusion. J Neuroimaging 2006;16:323–328.
4.
Tsivgoulis G, Sharma VK, Hoover SL, Lao AY, Ardelt AA, Malkoff MD, Alexandrov AV: Applications and advantages of power motion-mode Doppler in acute posterior circulation cerebral ischemia. Stroke 2008;39:1197–1204.
5.
Kim YS, Meyer JS, Garami Z, Molina CA, Pavlovic AM, Alexandrov AV: Flow diversion in transcranial Doppler ultrasound is associated with better improvement in patients with acute middle cerebral artery occlusion. Cerebrovasc Dis 2006;21:74–78.
6.
Babikian VL, Vijman CA, Hyde C, Cantelmo NL, Winter MR, Baker E, Pochay V: Cerebral microembolism and early recurrent cerebral or retinal ischemic events. Stroke 1997;28:1314–1318.
7.
Alexandrov AV, Nguyen HT, Rubiera M, Alexandrov AW, Zhao L, Heliopoulos I, Robinson A, Dewolfe J, Tsivgoulis G: Prevalence and risk factors associated with reversed Robin Hood syndrome in acute ischemic stroke. Stroke 2009;40:2738–2742.
8.
Tsivgoulis G, Sharma VK, Lao AY, Malkoff MD, Alexandrov AV: Validation of transcranial Doppler with computed tomography angiography in acute cerebral ischemia. Stroke 2007;38:1245–1249.
9.
Brunser A, Lavados P, Hoppe A, Lopez J, Valenzuela M, Rivas R: Accuracy of transcranial Doppler compared to CT angiography in diagnosing arterial obstructions in acute ischemic strokes. Stroke 2009;40:2037–2041.
10.
Chernyshev OY, Garami Z, Calleja S, Song J, Campbell MS, Noser EA, Shaltoni H, Chen CI, Iguchi Y, Grotta JC, Alexandrov AV: Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke 2005;36:32–37.
11.
Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Stroke 1993;24:35–41.
12.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
13.
Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170–2178.
14.
Moehring MA, Spencer MP: Power M-mode Doppler (PMD) for observing cerebral blood flow and tracking emboli. Ultrasound Med Biol 2002;28:49–57.
15.
Rathakrishnan R, Berne YI, Quek KK, Hong CS, Ong BK, Chan BP, Sharma VK: Validation of transcranial Doppler with CT angiography in cerebral ischaemia: a preliminary pilot study in Singapore. Ann Acad Med Singapore 2008;37:402–405.
16.
Wardlaw JM, Offin R, Teasdale GM: Is routine transcranial Doppler ultrasound monitoring useful in management of SAH. J Neurosurg 1998;88:272–276.
17.
Grupo de trabajo de Neurointensivismo y Trauma de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMIYUC); Grupo de trabajo de Neurología Crítica de la Societat Catalana de Medicina Intensiva i Crítics (SOCMIC): Clinical use of transcranial Doppler in critical neurological patients. Results of a multicenter study. Med Clin (Barc) 2003;120:241–245.
18.
Saqqur M, Shuaib S, Alexandrov A, Hill M, Calleja S, Tomsick T, Broderick J, Demchuk AM: Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis: multicenter experience from the Interventional Management of Stroke study. Stroke 2005;36:865–868.
19.
Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV: Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89–93.
20.
Kunz A, Hahn G, Mucha D, Müller A, Barrett KM, von Kummer R, Gahn G: Echo-enhanced transcranial color-coded duplex sonography in the diagnosis of cerebrovascular events: a validation study. AJNR Am J Neuroradiol 2006;27:2122–2127.
21.
Alexandrov AV, Felberg RA, Demchuk AM, Christou I, Burgin WS, Malkoff M, Wojner AW, Grotta JC: Deterioration following spontaneous improvement sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 2000;31:915–919.
22.
Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59:862–867.
23.
Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Shuaib A, Alexandrov AV; CLOTBUST Investigators: Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study. Cerebrovasc Dis 2009;27:5–12.
24.
Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Siddiqui M, Alvarez-Sabín J, Uchino K, Calleja S, Alexandrov AV; CLOTBUST Investigators: Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology 2008;71:1304–1312.
25.
Malferrari G, Bertolino C, Casoni F, Zini A, Sarra VM, Sanguigni S, Pratesi M, Lochner P, Coppo L, Brusa G, Guidetti D, Cavuto S, Marcello N; Eligible Group; SINV Group: The Eligible study: ultrasound assessment in acute ischemic stroke within 3 hours. Cerebrovasc Dis 2007;24:469–476.
26.
Allendoerfer J, Goertler M, von Reutern GM; Neurosonology in Acute Ischemic Stroke Study Group: Prognostic relevance of ultra-early Doppler sonography in acute ischaemic stroke: a prospective multicentre study. Lancet Neurol 2006;5:835–840.
27.
Sharma VK, Tsivgoulis G, Lao AY, Malkoff MD, Alexandrov AV: Noninvasive detection of diffuse intracranial disease. Stroke 2007;38:3175–3181.
28.
Marinoni M, Ginanneschi A, Forleo P, Amaducci L: Technical limits in transcranial Doppler recording: inadequate acoustic windows. Ultrasound Med Biol 1997;23:1275–1277.
29.
Itoh T, Matsumoto M, Handa N, Maeda H, Hougaku H, Hashimoto H, Etani H, Tsukamoto Y, Kamada T: Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. Stroke 1993;24:1192–1195.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.